Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in In

Bio Farma's Bio-TCV typhoid conjugate vaccine licensed in Indonesia following marketing approval

The International Vaccine Institute (IVI), an international organization with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health, and Bio Farma, a biotechnology company based in West Java, Indonesia, announced today that Bio Farma's Bio-TCV typhoid conjugate vaccine (TCV) was licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.

Related Keywords

West Java , Jawa Barat , Indonesia , Bio Farma , Sushant Sahastrabuddhe , Duncan Steele , Shadiq Akasya , Badan Pengawas Obat , National Agency For Drug , Vaccine Alliance , International Vaccine Institute , World Health Organization , Melinda Gates Foundation , Melinda Gates , Acting Deputy Director General , President Director , National Agency , Food Control , Deputy Director , Strategic Lead , Enteric Vaccines , Typhoid , Vaccine , Biotechnology , Cholera , Diphtheria , Fever , Global Health , Infectious Diseases , Polio , Reclinical , Protein , Public Health , Almonella , Technology , Typhoid Fever ,

© 2025 Vimarsana